Georgia Rep. Mark Newton, Academic Innovators, & Industry Leaders to be Honored at Georgia Life Sciences Summit in October

Georgia Bio, the state’s life science trade association, will honor the 2024 Golden Helix awardees October 21 at the opening reception of the Georgia Life Sciences Summit.

 

The Golden Helix Awards celebrate the contributions and achievements of Georgia legislative, academic, corporate, and advocacy leaders working to advance the growth of the life sciences industry and foster strategic partnerships that can create a healthier world. Traditionally, awardees are honored each spring at the awards gala, but this year Georgia Bio leadership decided to celebrate at the organization’s largest annual gathering. The Georgia Life Sciences Summit is expected to draw 350+ of the state’s life sciences industry leaders and will kick off with a Georgia Company Showcase highlight the best of the state’s emerging companies. 

 

“The life sciences community strives to improve patients’ lives, reduce our environmental footprint, use less and cleaner energy, and support workforce development, all while growing Georgia’s bioeconomy” said Georgia Bio CEO Maria Thacker Goethe, “The Golden Helix Awards highlights those lasting contributions made by many in the life sciences sector in Georgia.” 

 

Companies being honored with the distinguished Deal of the Year award include: Veranex for the acquisition of leading preclinical services provider T3 Labs; Werfen for the acquisition of transfusion and transplant diagnostics leader Immucor; life sciences manufacturer Meissner’s nearly $250 million investment into a new manufacturing facility in Athens-Clarke County; Dalan Animal Health’s $4.5M series seed 3 funding to accelerate global expansion and product pipeline; Inhibikase Therapeutics’ $10M raise for the development of treatments for Parkinson’s Disease and chronic myelogenous leukemia; Micron Biomedical’s $23.6M from the Bill & Melinda Gates Foundation to accelerate commercial manufacturing of their needle-free vaccines; and the NIH grant awarded to Emory, Georgia Tech & Children’s Healthcare to advance diagnostics. The Legislator of the Year Award will honor Georgia Representative Mark Newton of 127th House District for his leadership in sponsoring the rebate pass through bill in 2023, and his overall work on behalf of patients in Georgia.

 

The Metro Atlanta Chamber will present this year's Phoenix Award for life sciences to Wellstar MCG Health. This award celebrates the best industry and academic collaboration. The 2023 union of Wellstar and Augusta University is a move that bolsters healthcare in the region and will advance innovation.

 

The awards were selected by a small, distinguished committee of leaders in the Georgia ecosystem who assessed nominations and transactions closed between January 1, 2023 -December 31, 2023.

 

AWARD WINNERS  

 

Legislator of the Year Award: Presented to state legislators for their support of the life sciences industry in Georgia. 

  • The Honorable Mark Newton M.D., Georgia House of Representatives

 

Phoenix Award:  The Phoenix award represents the iconic "rising from the ashes" of the Phoenix, a symbol of strength, tenacity and leadership and is presented to celebrate the best Industry and Academic collaborations, outstanding healthcare professionals and systems, or other partnerships that drive translation and lead to new treatments and cures. This award is sponsored by the Metro Atlanta Chamber.  

  • Wellstar MCG Health

 

Deals of the Year Awards: Presented to one or more companies or institutions for the most significant financial or commercial transactions closed from January 1, 2022-December 31, 2022, based on the importance of the transaction to Georgia’s life sciences industry.  

 

Acquisitions  

  • Veranex completes acquisition of T3 Labs
  • Werfen completes acquisition of Immucor, Inc.

 

Economic Development

  • Meissner

 

Private Financing 

  • Dalan Animal Health
  • Inhibikase Therapeutics
  • Micron Biomedical

 

Public Financing 

  • Emory, Georgia Tech & Children’s Healthcare land major NIH grant for diagnostics

 

Community Awards: Presented to a small number of individuals, companies or institutions whose contributions to Georgia’s life sciences community are worthy of special recognition.  

  • Emily Blum, Global Center for Medical Innovation
  • Ashley Cornelison, Portal Innovations
  • Betty Pace, Georgia Cancer Center, Augusta University
  • Connor Seabrook, Georgia Research Alliance
  • The United States Patent and Trademark Office (USPTO) New Atlanta Regional Office

 

Innovation Awards: Presented to the department, institution, company or individuals who are forging new ground by thinking outside traditional paradigms to create some unique technology. 

  • Tom Barrows, ProgenaCare Global - ProgenaMatrix®
  • Jack Huang, University of Georgia - DE-FLUORO

 

Emerging Leader of the Year Awards: Presented to young individuals who have made a significant impact on the life sciences industry through their studies or employment. 

  • Eddie Lai, Metro Atlanta Chamber

 

Teacher of the Year Award: Presented to a Georgia biotechnology high school teacher who exhibits excellence in STEM teaching and support for the biotechnology pathway.  

  • Emily Gunderson, Empower College and Career Center, Jackson County

 

For a list of past award recipients, click here.  

 

# # # 

 

About Georgia Bio 

Georgia Bio (GaBio) is the state’s most impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For over 30 years, GaBio has served its members by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in biotechnology, pharmaceuticals, and medical technology. GaBio also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this vibrant sector. GaBio works to shape public policy, improve access to breakthrough technologies, educate lawmakers, provide member programs, strengthens the workforce pipeline, and advance equity within our ecosystem by championing innovative solutions for some of the most pressing challenges of our times. For more information, visit www.gabio.org. 

 

MEDIA CONTACT: 

Melissa Carter 

404-920-2043 

mcarter@gabio.org

Georgia Life Sciences Designates City of Atlanta as Newest BioReady® Community

By Sheran Brown • February 21, 2025
Georgia Life Sciences Designates City of Atlanta as Newest BioReady® Community

Bipartisan PBM Reform Back in Focus as House Committee Plans Hearing

By Sheran Brown • February 20, 2025
A renewed push for prescription drug cost reform is gaining momentum in Congress, with the House Energy and Commerce Committee's health subcommittee planning a hearing on pharmacy benefit manager (PBM) reform for late February. The hearing, to be led by Rep. Buddy Carter (R-Ga.), signals a revival of bipartisan efforts to regulate these pharmaceutical intermediaries. PBMs, which negotiate drug prices for insurers and employers, have become a focal point in the broader discussion of healthcare costs. A previous bipartisan agreement to regulate these entities was crafted by Carter and Rep. Diana DeGette (D-Colo.) in the last Congress, though it ultimately stalled when the larger spending bill it was attached to faced opposition. The reform efforts enjoy broad support from both parties and the president, making it one of the few areas with potential for bipartisan cooperation. However, new complications have emerged as Republicans consider using PBM regulations to generate savings for their broader policy agenda, potentially requiring up to $880 billion in cost reductions. The path forward remains uncertain, with ongoing debates about whether such reforms would qualify for budget reconciliation and whether using PBM regulations as a funding mechanism could derail bipartisan cooperation. Meanwhile, stakeholders continue to disagree on the impact of additional PBM regulation, with pharmaceutical companies arguing that PBMs inflate drug costs while PBMs contend that new regulations would increase prices.

Council on State Biotechnology Associations says NIH funds are a critical component of innovation ecosystem

By Sheran Brown • February 20, 2025
The Council of State Biotechnology Associations (CSBA) has issued a strong warning about proposed cuts to National Institutes of Health (NIH) funding, emphasizing the critical role these grants play in America's biotech innovation ecosystem. The statement, below , comes amid concerns over recent guidance that would reduce NIH funding to key research institutions. ----------------------- “Today, the US biotech industry employs nearly 2.3 million people across the US and is making positive contributions to economic impact and national security across all 50 states. In fact, for every dollar the National Institutes of Health (NIH) contributes to a successful drug, the private sector invests over $65, underscoring the agency’s unparalleled return on investment. As the associations representing the bioscience industry across the nation, the Council on State Biotechnology Associations (CSBA) is concerned by recent guidance that would cut funding provided by the NIH to universities, hospitals, and other institutions that perform critical early-stage research. NIH grant funds are a critical component of our innovation ecosystem. Grants for basic research are the spark that leads to university-driven discoveries, with public-private partnerships and tech transfers that bridge early-stage research to industry-sponsored drug development and ultimately to FDA approved medical advances for hundreds of diseases. While the administration looks for greater efficiency in the use of taxpayer dollars, it cannot be overstated - once scientific innovation moves abroad, it may never return. In the race for scientific innovation around the world, as our adversaries continue to increase government investments in research, we encourage President Trump to follow suit and ensure that we maintain our global leadership in an industry that was created and thrives across the US.”
MORE POSTS
Share by: